Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database

INTRODUCTION: Infliximab (IFX) was the first anti-tumor necrosis factor (TNFα) antibody to be used in the treatment of severe chronic inflammatory diseases, such as Crohn’s disease and rheumatoid arthritis. A number of serious adverse drug reactions are known to be associated with IFX use; they incl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Thillard, Eve-Marie, Gautier, Sophie, Babykina, Evgeniya, Carton, Louise, Amad, Ali, Bouzillé, Guillaume, Beuscart, Jean-Baptiste, Ficheur, Grégoire, Chazard, Emmanuel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188945/
https://ncbi.nlm.nih.gov/pubmed/32390850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00513
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak